|
시장보고서
상품코드
2075221
난임 검사 시장 : 제품별, 구입 방법별, 용도별, 최종사용자별 및 지역별Fertility Test Market, By Product, By Mode of Purchase, By Application, and By End User, and By Geography |
||||||
난임 검사는 2026년에 7억 2,670만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 12억 4,550만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.0%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 7억 2,670만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.00% | 2033년 시장 규모 예측 : | 12억 4,550만 달러 |
임신 가능성 검사는 배란 여부를 확인하거나, 자연 임신이 어려운 상태인 불임증의 진단에 활용됩니다. 이는 남녀 모두 자신의 생식능력과 이와 관련된 다양한 상태를 평가하기 위해 실시됩니다. 남녀 모두 불임 문제에 직면하는 비율은 거의 비슷하지만, 여성들이 임신 가능성 검사에 대해 더 큰 관심을 가지고 있는 것으로 알려져 있습니다.
시장 역학 :
남녀의 출산율 감소, 불임 검사 기기에 대한 대중의 인식 제고, 불임 검사 기기의 수요 및 보급 확대, 그리고 여성의 다낭성난소증후군(PCOS) 유병률 증가가 예측 기간 중 전 세계 불임 검사 시장의 성장을 촉진할 것으로 예상되는 주요 요인입니다.
예를 들어 전 세계에서 볼 때 출산율은 1950년 여성 1인당 평균 5명에서 2021년에는 2.3명으로 감소했는데, 이는 사람들이 자신의 생식 생활을 더 잘 통제할 수 있게 되었음을 보여줍니다. 유엔의 '2022년 세계 인구 전망(WPP)' 보고서에 따르면 2021년 전 세계에서 2.3이었던 총출산율은 전 세계에서 출산율이 동시에 감소하고 있는 상황에서 2050년까지 인구 전환점인 2.1에 도달할 것으로 예측됩니다.
또한 유로스타트가 발표한 최신 인구 추계에 따르면 2022년 1월 1일부터 2100년 1월 1일까지의 기간 중 EU 인구는 6% 감소할 것으로 예상되며, 이는 2,730만 명의 감소에 해당합니다. 유로스타트가 2022년 4월에 발표한 자료에 따르면 2020년에는 유럽연합 전역에서 출생률이 하락했으며, 출생 수는 400만 명으로 60년 만에 최저치를 기록했습니다.
본 조사의 주요 특징 :
- 이 조사에서는 다양한 부문의 잠재적 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 조사에서는 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 임신 가능성 검사 분야의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 이 보고서의 시장 잠재력 분석 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 생식력 검사에 대한 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 난임 검사
제5장 세계의 난임 검사 : 제품별, 2021-2033년
제6장 세계의 난임 검사 : 구입 방법별, 2021-2033년
제7장 세계의 난임 검사 : 용도별, 2021-2033년
제8장 세계의 난임 검사 : 최종사용자별, 2021-2033년
제9장 세계의 난임 검사 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 섹션
KSAFertility Test Market is estimated to be valued at USD 726.7 Mn in 2026 and is expected to reach USD 1,245.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 726.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.00% | 2033 Value Projection: | USD 1,245.5 Mn |
Fertility test can be used to detect ovulation and/or to diagnose infertility, an inability to reproduce by natural means. It is done by both men and women to assess their fertility and various conditions associated with it. Both men and women experience fertility problems at about the same rate, but women are known to be more concerned about fertility testing.
Market Dynamics:
Declining fertility rates among men and women, increasing awareness among people about fertility testing devices, increasing demand or adoption of fertility testing devices, and growing prevalence of PCOS (Polycystic Ovary Syndrome) among women are major factors expected to augment the growth of the global fertility test market during the forecast period.
For instance, globally, the fertility has fallen from an average of 5 births per woman in 1950 to 2.3 births per woman in 2021, an indication of the increasing control that people are able to exercise over their reproductive lives. According to the United Nation's World Population Prospects 2022 (WPP) report, the global fertility rate, which stood at 2.3 overall in 2021, will hit the demographic tipping point of 2.1 by 2050, due to a globally synchronized decline in birth rates.
Moreover, according to the latest population projections issued by Eurostat, the EU's population will decrease by 6% between 1 January 2022 and 1 January 2100, equivalent to 27.3 million fewer people. A birth rate declined across the European Union in 2020, hitting a 60-year low of 4 million births, according to data published by Eurostat in April 2022.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global fertility test market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Advacare Pharma, UEBE Medical, Abbott Laboratories, Quidel Corporation, HiLin Life Products Inc., Geratherm Medical AG, Fertility Focus Limited, Fairhaven Health LLC, Church & Dwight Co. Inc., and Prestige Brands Holdings Inc., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global fertility test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fertility test market.
Detailed Segmentation:
- Global Fertility Test Market, By Product (Revenue, USD Mn, 2021 - 2033)
- Ovulation Prediction Kit
- Fertility Monitors
- Urine-based Ovulation Monitors
- Saliva-based Ovulation Monitors
- Other Fertility Monitors
- Male Fertility Testing Products
- Global Fertility Test Market, By Mode of Purchase (Revenue, USD Mn, 2021 - 2033)
- OTC-based Products
- Prescription-based Products
- Global Fertility Test Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Female Fertility Testing
- Male Fertility Testing
- Global Fertility Test Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Home Care Setting
- Hospitals/Fertility Testing
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Advacare Pharma
- UEBE Medical
- Abbott Laboratories
- Quidel Corporation
- HiLin Life Products Inc.
- Geratherm Medical AG
- Fertility Focus Limited
- Fairhaven Health LLC
- Church & Dwight Co. Inc.
- Prestige Brands Holdings Inc.
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Mode of Purchase
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Declining fertility rates among men and women
- High cost of fertility testing monitors
- High demand/adoption of fertility testing devices
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Global Fertility Test Market
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Fertility Test Market, By Product, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Ovulation Prediction Kit
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Fertility Monitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Urine-based Ovulation Monitors
- Saliva-based Ovulation Monitors
- Other Fertility Monitors
- Male Fertility Testing Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Fertility Test Market, By Mode of Purchase, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- OTC-based Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Prescription-based Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Fertility Test Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Female Fertility Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Male Fertility Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
8. Global Fertility Test Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Home Care Setting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Hospitals/Fertility Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
9. Global Fertility Test Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Purchase, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Purchase, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Purchase, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Purchase, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Purchase, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Purchase, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
10. Competitive Landscape
- Advacare Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- UEBE Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quidel Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HiLin Life Products Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Geratherm Medical AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fertility Focus Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fairhaven Health LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Church & Dwight Co. Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Prestige Brands Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
